𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Thyroid lymphoma. The case for combined modality therapy

✍ Scribed by Raul Doria; James F. Jekel; Dennis L. Cooper

Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
636 KB
Volume
73
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Combined therapy for thyroid squamous ce
Combined therapy for thyroid squamous cell carcinoma
✍ Filip Yves F. L. De Vos; Aniel Sewnaik; J. Hans W. de Wilt; Ernst J. Smid; Micha πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 549 KB

## Abstract ## Background. Squamous carcinoma of the thyroid is a rare aggressive disease, resulting in poor prognosis. ## Methods and Results. We combined cisplatin with paclitaxel on a weekly basis as induction therapy, achieving a high cumulative dose, in a patient with squamous cell tumor of

Photodynamic therapy: Combined modality
Photodynamic therapy: Combined modality approaches targeting the tumor microenvironment
✍ Charles J. Gomer; Angela Ferrario; Marian Luna; Natalie Rucker; Sam Wong πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 74 KB

## Abstract ## Background and Objectives Photodynamic therapy causes direct cytotoxicity to malignant cells within a tumor. Photodynamic therapy (PDT) can also have both direct and indirect effects upon various non‐malignant components of the tumor microenvironment. This action can lead to PDT‐med